Nejadi Jahanbakhsh R, Shamseh Mahnaz, Ronasi Nooshin, Birjandi Mehdi, Karimi Arash
Department of Anesthesiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Departments of Biostatistics and Epidemiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Curr Rev Clin Exp Pharmacol. 2021;16(1):117-122. doi: 10.2174/1574884715666200302122800.
Postoperative Nausea and Vomiting (PONV) is a common complication associated with the use of anesthesia. Several antiemetics are used to reduce the incidence and severity of PONV. The aim of this study was to investigate the role of dexamethasone and ondansetron to treat PONV in patients undergoing cesarean section (c-section) under spinal anesthesia.
This double-blind clinical trial study was performed on patients who were referred to Haji Karim Asali Hospital of Khorramabad for elective cesarean section in 2016-17. Upon meeting the inclusion criteria, patients were allotted into two groups (n=60). Group A received 8mg of dexamethasone and group B received 4mg of ondansetron after spinal anesthesia. The Visual Analog Scale (VAS) questionnaire and Depression-Anxiety-Stress Scale (DASS) questionnaire were used for the analysis. Patients with mild to moderate stress, anxiety, and depression were included in the study. Data were analyzed using SPSS 16 software.
There was no difference in the demographic data of the two groups. The mean severity of nausea in group A was significantly higher than in group B. The odd ration of PONV was 20.67, which was found to be statistically significant, p = 0.018. Concerning the type of delivery with the frequency of nausea, the results showed that the frequency of nausea in group A was 3.24 times higher than group B, however, this difference was not statistically significant, p = 0.106.
Based on the results of this study, ondansetron had a significant effect on the alleviation of postoperative nausea and vomiting, as compared to dexamethasone in C-section surgical candidates.
术后恶心呕吐(PONV)是与麻醉使用相关的常见并发症。几种止吐药用于降低PONV的发生率和严重程度。本研究的目的是探讨地塞米松和昂丹司琼在脊髓麻醉下剖宫产患者中治疗PONV的作用。
这项双盲临床试验研究于2016 - 17年对转诊至霍拉马巴德哈吉卡里姆·阿萨利医院进行择期剖宫产的患者进行。符合纳入标准后,患者被分为两组(n = 60)。A组在脊髓麻醉后接受8mg地塞米松,B组接受4mg昂丹司琼。使用视觉模拟量表(VAS)问卷和抑郁 - 焦虑 - 压力量表(DASS)问卷进行分析。纳入轻度至中度应激、焦虑和抑郁的患者进行研究。数据使用SPSS 16软件进行分析。
两组的人口统计学数据无差异。A组恶心的平均严重程度显著高于B组。PONV的比值比为20.67,发现具有统计学意义,p = 0.018。关于分娩类型与恶心频率,结果显示A组恶心频率比B组高3.24倍,然而,这种差异无统计学意义,p = 0.106。
基于本研究结果,与地塞米松相比,昂丹司琼对剖宫产手术候选者术后恶心呕吐的缓解有显著效果。